JBC Focus on PI3-Kinase with Echelon

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, X.-C.
Right arrow Articles by Sumners, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, X.-C.
Right arrow Articles by Sumners, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 26, Issue of June 28, 1996 pp. 15635-15641
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Mitogen-activated Protein Kinases in Rat Brain Neuronal Cultures Are Activated by Angiotensin II Type 1 Receptors and Inhibited by Angiotensin II Type 2 Receptors

(Received for publication, December 26, 1995, and in revised form, March 7, 1996)

Xian-Cheng Huang , Elaine M. Richards and Colin Sumners

From the Department of Physiology, College of Medicine, University of Florida, Gainesville, Florida 32610

Neurons cultured from neonatal rat hypothalamus and brainstem contain many angiotensin II (Ang II) type 2 (AT2) receptors, and we previously determined that activation of these sites elicited a stimulation of serine/threonine phosphatase 2A (PP2A). Here, we have investigated the effects of Ang II on neuronal mitogen-activated protein (MAP) kinases, potential targets for PP2A. Using in-gel kinase assays and immunoprecipitation analyses we have shown that Ang II (10 nM-1 µM) elicits significant increases in p44MAPK (Erk1) and p42MAPK (Erk2) activities in cultured neurons, mediated via Ang II type 1 (AT1) receptors. This stimulatory effect of Ang II on Erk1 and Erk2 activities was potentiated by blockade of AT2 receptors with (S)-1-[4-(dimethylamino)-3-methylphenyl]methyl-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-C]pyridine-6-carboxylic acid (PD 123319, 1 µM). Furthermore, the AT2 receptor agonist N-alpha -nicotinoyl-Tyr-Lys-(N-alpha CBZ-Arg)-His-Pro-Ile-OH (CGP42112A) (10-50 nM) caused significant decreases in neuronal Erk1 and Erk2 activities, which were abolished by PD 123319 (1 µM) and by the PP2A inhibitor okadaic acid (3 nM). This indicates that AT1 and AT2 receptors have opposite actions on Erk1 and Erk2 activities in neonatal neurons. Since MAP kinases are involved in the regulation of growth/differentiation and apoptosis, our data may provide an intracellular basis for modulatory effects of Ang II receptors on these processes.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
P. Kilian, S. Campbell, L. Bilodeau, M.-O. Guimond, C. Roberge, N. Gallo-Payet, and M. D. Payet
Angiotensin II Type 2 Receptor Stimulation Increases the Rate of NG108-15 Cell Migration via Actin Depolymerization
Endocrinology, June 1, 2008; 149(6): 2923 - 2933.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
Z. Shan, A. E. Cuadra, C. Sumners, and M. K. Raizada
Characterization of a functional (pro)renin receptor in rat brain neurons
Exp Physiol, May 1, 2008; 93(5): 701 - 708.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Yan, A. J. T. Schuldt, R. L. Price, I. Amende, F.-F. Liu, K. Okoshi, K. K. L. Ho, A. J. Pope, T. K. Borg, B. H. Lorell, et al.
Pressure overload-induced hypertrophy in transgenic mice selectively overexpressing AT2 receptors in ventricular myocytes
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1274 - H1281.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Q. Zhang, F. He, R. Kuruba, X. Gao, A. Wilson, J. Li, T. R. Billiar, B. R. Pitt, W. Xie, and S. Li
FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells
Cardiovasc Res, February 1, 2008; 77(3): 560 - 569.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J.-M. Li, M. Mogi, K. Tsukuda, H. Tomochika, J. Iwanami, L.-J. Min, C. Nahmias, M. Iwai, and M. Horiuchi
Angiotensin II-Induced Neural Differentiation via Angiotensin II Type 2 (AT2) Receptor-MMS2 Cascade Involving Interaction between AT2 Receptor-Interacting Protein and Src Homology 2 Domain-Containing Protein-Tyrosine Phosphatase 1
Mol. Endocrinol., February 1, 2007; 21(2): 499 - 511.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. Paul, A. Poyan Mehr, and R. Kreutz
Physiology of local Renin-Angiotensin systems.
Physiol Rev, July 1, 2006; 86(3): 747 - 803.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. D'Amore, M. J. Black, and W. G. Thomas
The Angiotensin II Type 2 Receptor Causes Constitutive Growth of Cardiomyocytes and Does Not Antagonize Angiotensin II Type 1 Receptor-Mediated Hypertrophy
Hypertension, December 1, 2005; 46(6): 1347 - 1354.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Modesti, I. Bertolozzi, T. Gamberi, M. Marchetta, C. Lumachi, M. Coppo, F. Moroni, T. Toscano, G. Lucchese, G. F. Gensini, et al.
Hyperglycemia Activates JAK2 Signaling Pathway in Human Failing Myocytes via Angiotensin II-Mediated Oxidative Stress
Diabetes, February 1, 2005; 54(2): 394 - 401.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W.-P. Koh, J.-M. Yuan, D. Van Den Berg, H.-P. Lee, and M. C. Yu
Polymorphisms in angiotensin II type 1 receptor and angiotensin I-converting enzyme genes and breast cancer risk among Chinese women in Singapore
Carcinogenesis, February 1, 2005; 26(2): 459 - 464.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
X. Li, K. M. Lerea, J. Li, and S. C. Olson
Src Kinase Mediates Angiotensin II-Dependent Increase in Pulmonary Endothelial Nitric Oxide Synthase
Am. J. Respir. Cell Mol. Biol., September 1, 2004; 31(3): 365 - 372.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Olson, R. Oeckler, X. Li, L. Du, F. Traganos, X. Zhao, and T. Burke-Wolin
Angiotensin II stimulates nitric oxide production in pulmonary artery endothelium via the type 2 receptor
Am J Physiol Lung Cell Mol Physiol, September 1, 2004; 287(3): L559 - L568.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Hoffmann, D. Podlich, B. Hahnel, W. Kriz, and N. Gretz
Angiotensin II Type 1 Receptor Overexpression in Podocytes Induces Glomerulosclerosis in Transgenic Rats
J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1475 - 1487.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
O. Johren, A. Dendorfer, and P. Dominiak
Cardiovascular and renal function of angiotensin II type-2 receptors
Cardiovasc Res, June 1, 2004; 62(3): 460 - 467.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
N. Hashimoto, Y. Maeshima, M. Satoh, M. Odawara, H. Sugiyama, N. Kashihara, H. Matsubara, Y. Yamasaki, and H. Makino
Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model
Am J Physiol Renal Physiol, March 1, 2004; 286(3): F516 - F525.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Suarez, G. Diaz-Torga, A. Gonzalez-Iglesias, J. Vela, A. Mladovan, A. Baldi, and D. Becu-Villalobos
Angiotensin II phosphorylation of extracellular signal-regulated kinases in rat anterior pituitary cells
Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E645 - E653.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. A. Fleegal and C. Sumners
Drinking behavior elicited by central injection of angiotensin II: roles for protein kinase C and Ca2+/calmodulin-dependent protein kinase II
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R632 - R640.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Q. Liu and P. A. Hofmann
Modulation of protein phosphatase 2a by adenosine A1 receptors in cardiomyocytes: role for p38 MAPK
Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H97 - H103.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Gendron, J.-F. Oligny, M. D. Payet, and N. Gallo-Payet
Cyclic AMP-independent Involvement of Rap1/B-Raf in the Angiotensin II AT2 Receptor Signaling Pathway in NG108-15 Cells
J. Biol. Chem., January 31, 2003; 278(6): 3606 - 3614.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Baetz, R. S. Haworth, M. Avkiran, and D. Feuvray
The ERK pathway regulates Na+-HCO3- cotransport activity in adult rat cardiomyocytes
Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H2102 - H2109.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. A. F. de Godoy and A. M. de Oliveira
Cross-Talk Between AT1 and AT2 Angiotensin Receptors in Rat Anococcygeus Smooth Muscle
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 333 - 339.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Q. Liu and P. A. Hofmann
Antiadrenergic effects of adenosine A1 receptor-mediated protein phosphatase 2a activation in the heart
Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1314 - H1321.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Berry, R. Touyz, A. F. Dominiczak, R. C. Webb, and D. G. Johns
Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide
Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2337 - H2365.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Shibasaki, H. Matsubara, Y. Nozawa, Y. Mori, H. Masaki, A. Kosaki, Y. Tsutsumi, Y. Uchiyama, S. Fujiyama, A. Nose, et al.
Angiotensin II Type 2 Receptor Inhibits Epidermal Growth Factor Receptor Transactivation by Increasing Association of SHP-1 Tyrosine Phosphatase
Hypertension, September 1, 2001; 38(3): 367 - 372.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Hines, J. N. Heerding, S. J. Fluharty, and D. K. Yee
Identification of Angiotensin II Type 2 (AT2) Receptor Domains Mediating High-Affinity CGP 42112A Binding and Receptor Activation
J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 665 - 673.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. D. Everett, T. D. Stoops, A. C. Nairn, and D. Brautigan
Angiotensin II regulates phosphorylation of translation elongation factor-2 in cardiac myocytes
Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H161 - H167.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
J. Culman, J. Baulmann, A. Blume, and T. Unger
Review: The renin-angiotensin system in the brain: an update
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2001; 2(2): 96 - 102.
[PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. Moellenhoff, A. Blume, J. Culman, B. Chatterjee, T. Herdegen, C. J. Lebrun, and T. Unger
Effect of repetitive icv injections of ANG II on c-Fos and AT1-receptor expression in the rat brain
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R1095 - R1104.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T.-X. Cui, H. Nakagami, M. Iwai, Y. Takeda, T. Shiuchi, L. Daviet, C. Nahmias, and M. Horiuchi
Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell
Cardiovasc Res, March 1, 2001; 49(4): 863 - 871.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
H. Peng, J. Moffett, J. Myers, X. Fang, E. K. Stachowiak, P. Maher, E. Kratz, J. Hines, S. J. Fluharty, E. Mizukoshi, et al.
Novel Nuclear Signaling Pathway Mediates Activation of Fibroblast Growth Factor-2 Gene by Type 1 and Type 2 Angiotensin II Receptors
Mol. Biol. Cell, February 1, 2001; 12(2): 449 - 462.
[Abstract] [Full Text]


Home page
Physiol. Rev.Home page
E. Feraille and A. Doucet
Sodium-Potassium-Adenosinetriphosphatase-Dependent Sodium Transport in the Kidney: Hormonal Control
Physiol Rev, January 1, 2001; 81(1): 345 - 418.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
Chiming Wei, M. G Cardarelli, S. W Downing, and J. S McLaughlin
The effect of angiotensin II on mitogen-activated protein kinase in human cardiomyocytes
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2000; 1(4): 379 - 384.
[Abstract] [PDF]


Home page
Mol. Pharmacol.Home page
J. A. Olivares-Reyes, S. Jayadev, L. Hunyady, K. J. Catt, and R. D. Smith
Homologous and Heterologous Phosphorylation of the AT2 Angiotensin Receptor by Protein Kinase C
Mol. Pharmacol., November 1, 2000; 58(5): 1156 - 1161.
[Abstract] [Full Text]


Home page
CirculationHome page
M. Akishita, M. Iwai, L. Wu, L. Zhang, Y. Ouchi, V. J. Dzau, and M. Horiuchi
Inhibitory Effect of Angiotensin II Type 2 Receptor on Coronary Arterial Remodeling After Aortic Banding in Mice
Circulation, October 3, 2000; 102(14): 1684 - 1689.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
N. Elbaz, K. Bedecs, M. Masson, M. Sutren, A. D. Strosberg, and C. Nahmias
Functional Trans-inactivation of Insulin Receptor Kinase by Growth-Inhibitory Angiotensin II AT2 Receptor
Mol. Endocrinol., June 1, 2000; 14(6): 795 - 804.
[Abstract] [Full Text]


Home page
HypertensionHome page
W. C. De Mello and A. H. J. Danser
Angiotensin II and the Heart : On the Intracrine Renin-Angiotensin System
Hypertension, June 1, 2000; 35(6): 1183 - 1188.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Goette, T. Staack, C. Rocken, M. Arndt, J. C. Geller, C. Huth, S. Ansorge, H. U. Klein, and U. Lendeckel
Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation
J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1669 - 1677.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Gallinat, S. Busche, M. K. Raizada, and C. Sumners
The angiotensin II type 2 receptor: an enigma with multiple variations
Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E357 - E374.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. M. Carey, Z.-Q. Wang, and H. M. Siragy
Role of the Angiotensin Type 2 Receptor in the Regulation of Blood Pressure and Renal Function
Hypertension, January 1, 2000; 35(1): 155 - 163.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Chamoux
Involvement of the Angiotensin II Type 2 Receptor in Apoptosis during Human Fetal Adrenal Gland Development
J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4722 - 4730.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
S. Gunasegaram, R. S. Haworth, D. J. Hearse, and M. Avkiran
Regulation of Sarcolemmal Na+/H+ Exchanger Activity by Angiotensin II in Adult Rat Ventricular Myocytes : Opposing Actions via AT1 Versus AT2 Receptors
Circ. Res., November 12, 1999; 85(10): 919 - 930.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Y. A. Lehtonen, L. Daviet, C. Nahmias, M. Horiuchi, and V. J. Dzau
Analysis of Functional Domains of Angiotensin II Type 2 Receptor Involved in Apoptosis
Mol. Endocrinol., July 1, 1999; 13(7): 1051 - 1060.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. Horiuchi, M. Akishita, and V. J. Dzau
Recent Progress in Angiotensin II Type 2 Receptor Research in the Cardiovascular System
Hypertension, February 1, 1999; 33(2): 613 - 621.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
U. V. Shenoy, E. M. Richards, X.-C. Huang, and C. Sumners
Angiotensin II Type 2 Receptor-Mediated Apoptosis of Cultured Neurons from Newborn Rat Brain
Endocrinology, January 1, 1999; 140(1): 500 - 509.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. J. Morrissey and S. Klahr
Effect of AT2 receptor blockade on the pathogenesis of renal fibrosis
Am J Physiol Renal Physiol, January 1, 1999; 276(1): F39 - F45.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Tsutsumi, H. Matsubara, N. Ohkubo, Y. Mori, Y. Nozawa, S. Murasawa, K. Kijima, K. Maruyama, H. Masaki, Y. Moriguchi, et al.
Angiotensin II Type 2 Receptor Is Upregulated in Human Heart With Interstitial Fibrosis, and Cardiac Fibroblasts Are the Major Cell Type for Its Expression
Circ. Res., November 16, 1998; 83(10): 1035 - 1046.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. M. Muthalif, I. F. Benter, N. Karzoun, S. Fatima, J. Harper, M. R. Uddin, and K. U. Malik
20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells
PNAS, October 13, 1998; 95(21): 12701 - 12706.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. Yang and C. D. Sigmund
Developmental expression of human angiotensinogen in transgenic mice
Am J Physiol Renal Physiol, May 1, 1998; 274(5): F932 - F939.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X.-C. Huang, T. Deng, and C. Sumners
Angiotensin II Stimulates Activation of Fos-Regulating Kinase and c-Jun NH2-Terminal Kinase in Neuronal Cultures from Rat Brain
Endocrinology, January 1, 1998; 139(1): 245 - 251.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. R. Uddin, M. M. Muthalif, N. A. Karzoun, I. F. Benter, and K. U. Malik
Cytochrome P-450 Metabolites Mediate Norepinephrine-Induced Mitogenic Signaling
Hypertension, January 1, 1998; 31(1): 242 - 247.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. R. Shah, J. Laredo, B. P. Hamilton, and J. M. Hamlyn
Different Signaling Pathways Mediate Stimulated Secretions Of Endogenous Ouabain and Aldosterone From Bovine Adrenocortical Cells
Hypertension, January 1, 1998; 31(1): 463 - 468.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J.-G. LeHoux, I. M. Bird, N. Briere, D. Martel, and L. Ducharme
Influence of Dietary Sodium Restriction on Angiotensin II Receptors in Rat Adrenals
Endocrinology, December 1, 1997; 138(12): 5238 - 5247.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. Drolet, L. Bilodeau, A. Chorvatova, L. Laflamme, N. Gallo-Payet, and M. D. Payet
Inhibition of the T-Type Ca2+ Current by the Dopamine D1 Receptor in Rat Adrenal Glomerulosa Cells: Requirement of the Combined Action of the G{beta}{gamma} Protein Subunit and Cyclic Adenosine 3',5'-Monophosphate
Mol. Endocrinol., April 1, 1997; 11(4): 503 - 514.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. L. Malek, R. E. Toman, L. C. Edsall, S. Wong, J. Chiu, C. A. Letterle, J. R. Van Brocklyn, S. Milstien, S. Spiegel, and N. H. Lee
Nrg-1 Belongs to the Endothelial Differentiation Gene Family of G Protein-coupled Sphingosine-1-phosphate Receptors
J. Biol. Chem., February 16, 2001; 276(8): 5692 - 5699.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE